20 September 2019 - U.S. lawmakers should also include in their proposals rules that would facilitate greater competition and innovation, Humana CEO Bruce Broussard says.
Legislation that would put a cap on prices pharmaceutical companies can charge for their prescription drugs can be effective in reducing health costs, Humana CEO Bruce Broussard said Friday.
But U.S. lawmakers should also include in their proposals rules that would facilitate greater competition and innovation, Broussard said in an interview with CNBC’s Bertha Coombs.